Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Kevin L Winthrop, MD, MPH (he/him/his)

Professor of Public Health, Infectious Diseases, Ophthalmology
Oregon Health & Science University
Portland, OR, United States

Kevin L. Winthrop, M.D., M.P.H.
Oregon Health & Science University, Portland, OR, USA
Kevin L. Winthrop is a Professor of Public Health at the Oregon Health & Science University-Portland State University School of Public Health (OHSU-PSU SPH), and a Professor of Infectious Diseases and Ophthalmology at the School of Medicine at Oregon Health & Science University in Portland, OR, USA.
Dr. Winthrop received his undergraduate degree in biology from Yale University, New Haven, CT, USA and his MD from OHSU. He completed his internal medicine residency training at Legacy Emanuel Hospital, Portland, OR. He completed an infectious disease epidemiology fellowship at the US Centers for Disease Control and Prevention. In 2003, Dr. Winthrop was conferred a Master in Public Health from the University of California, Berkley, CA, USA. In 2006, Dr. Winthrop returned to OHSU as Assistant Professor before progressing to his current appointment in 2018.
A former infectious disease epidemiologist in the Division of Tuberculosis Elimination at the US Centers for Disease Control and Prevention (CDC), Dr. Winthrop has co-authored over 400 publications, many regarding the epidemiologic and clinical aspects of opportunistic infections associated with immune-mediated inflammatory diseases, particularly those related to biologic immunosuppressive therapies.
As a primary or senior investigator in many clinical or epidemiologic studies in these fields, he has collaborated closely with the rheumatology community in the evaluation and prevention of opportunistic infections in that setting. In addition, he is also member of the graduate faculty at OHSU where he mentors public health students, medical students, and physicians in post-graduate training. At OHSU, he directs a national referral center for chronic chest infections, and he serves as the medical consultant to the State of Oregon’s Tuberculosis control program.





Disclosure(s): AN2 Therapeutics, Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Insmed Inc: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); MannKind: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Paratek Pharmaceuticals: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Renovion: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Spero theraputics: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)

Presentation(s):